Renal Cancer 2019

DOI: 10.1007/978-3-030-24378-4_5

|View full text |Cite

|

Sign up to set email alerts

|

Imaging of Renal Cancer

Jaclyn A. Therrien²,

Christoph Wald³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Imaging Characteristics5

Citation Types

Supporting

0

Mentioning

31

Contrasting

0

Year Published

2021

2021

2021

2021

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(31 citation statements)

References 56 publications

Supporting

0

Mentioning

31

Contrasting

0

Order By: Relevance

“…19,20 Imaging studies help to determine if a mass is a simple or hemorrhagic cyst, contains fat, inflammation, infection, infarction, lymphoma, sarcoma, Wilms tumor, or metastatic disease from the lungs, breasts, gastrointestinal tract, or melanoma. 18,19 CT with and without contrast is the predominant imaging study used to diagnose RCC. 4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…18,19 CT with and without contrast is the predominant imaging study used to diagnose RCC. 4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise. 19,20 Tissue examination may be in the form of a preoperative percutaneous renal mass biopsy (RMB) using ultrasound or CT guidance or from a mass excised during surgery.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise. 19,20 Tissue examination may be in the form of a preoperative percutaneous renal mass biopsy (RMB) using ultrasound or CT guidance or from a mass excised during surgery. Preoperative RMB is not always routinely performed in contemporary practice.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…21 On imaging, a solid renal mass may have a ball or bean shape. 18,19,21,22 Ball-type masses are characteristic of RCC and tend to expand and distort the renal contour, whereas beanshaped masses are not as prominent and do not distort the renal contour on imaging studies. 19,20,22,23 Ultrasonography is among the most common imaging studies of the abdomen and pelvis.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…18,19,21,22 Ball-type masses are characteristic of RCC and tend to expand and distort the renal contour, whereas beanshaped masses are not as prominent and do not distort the renal contour on imaging studies. 19,20,22,23 Ultrasonography is among the most common imaging studies of the abdomen and pelvis. Ultrasound can clearly differentiate renal cystic masses from solid masses and may be the initial step in determining whether a renal mass is benign or malignant.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

See 4 more Smart Citations

Renal cell carcinoma, part 1

¹

2021

View full text Add to dashboard Cite

July l Nursing2021 l 35 THE AUTHOR'S journey with chronic illness began in 1998 at age 40, with a diagnosis of systemic lupus erythematosus (SLE). SLE and medications used to treat the disease increase the risk for infection. Several years ago, computed tomography (CT) of the chest, performed to confirm a diagnosis of right lower lobe pneumonia, revealed a 3-cm mass. A diagnosis of renal cell carcinoma (RCC) followed, along with a growing acquaintance with this disease. A partial nephrectomy was performed to remove the cancer, enabling a cancer-free life for the past 2 years.This article, the first of a three-part series on RCC, will address the incidence and epidemiology of RCC along with its genetic alterations, risk factors, histologic characteristics, and imaging characteristics. The subsequent articles will address treatment options and take a more detailed look at nursing interventions. Incidence and epidemiologyThe incidence of renal malignancy is 6 per 100,000 men and 3 per 100,000 women. Of all malignancies globally, it ranks 9th in men and 14th in women. 1 In the US, the incidence is 21 per 100,000 men and 11 per 100,000 women, representing the sixth and eighth most common malignancies in men and women, respectively. 1,2 According to the American Cancer Society, about 76,080 new cases of kidney cancer (48,780 in men and 27,300 in women) will be diagnosed in 2021, and about 13,780 people will die from this disease. 3 Sometimes referred to as renal cell adenocarcinoma or hypernephroma, RCC accounts for at least 85% of all renal malignancies and occurs more often than benign renal masses. 3 The incidence of RCC is highest in North America, Australia, and Europe, and lowest in India, Japan, Africa, and China. 1,2,4 Morbidity and mortality associated with RCC is higher for Black Americans, Native Americans, and Hispanics than for White patients, which is likely related to socioeconomic stressors, disparities in access to healthcare, and comorbidities. 1,4,5 Pathophysiology RCC encompasses a group of malignancies that originate in the Abstract: Renal cell carcinoma (RCC) encompasses a group of malignancies that originate in the epithelium of the renal cortex, most often in the upper pole of the kidney. This article, the first of a three-part series on RCC, addresses the incidence and epidemiology of RCC along with its genetic alterations, risk factors, histologic characteristics, and imaging characteristics.

“…19,20 Imaging studies help to determine if a mass is a simple or hemorrhagic cyst, contains fat, inflammation, infection, infarction, lymphoma, sarcoma, Wilms tumor, or metastatic disease from the lungs, breasts, gastrointestinal tract, or melanoma. 18,19 CT with and without contrast is the predominant imaging study used to diagnose RCC. 4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…18,19 CT with and without contrast is the predominant imaging study used to diagnose RCC. 4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise. 19,20 Tissue examination may be in the form of a preoperative percutaneous renal mass biopsy (RMB) using ultrasound or CT guidance or from a mass excised during surgery.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…4,6,19,20 From a radiologic perspective, a suspicious renal mass on an imaging study is assumed to be malignant until tissue examination proves otherwise. 19,20 Tissue examination may be in the form of a preoperative percutaneous renal mass biopsy (RMB) using ultrasound or CT guidance or from a mass excised during surgery. Preoperative RMB is not always routinely performed in contemporary practice.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…21 On imaging, a solid renal mass may have a ball or bean shape. 18,19,21,22 Ball-type masses are characteristic of RCC and tend to expand and distort the renal contour, whereas beanshaped masses are not as prominent and do not distort the renal contour on imaging studies. 19,20,22,23 Ultrasonography is among the most common imaging studies of the abdomen and pelvis.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

“…18,19,21,22 Ball-type masses are characteristic of RCC and tend to expand and distort the renal contour, whereas beanshaped masses are not as prominent and do not distort the renal contour on imaging studies. 19,20,22,23 Ultrasonography is among the most common imaging studies of the abdomen and pelvis. Ultrasound can clearly differentiate renal cystic masses from solid masses and may be the initial step in determining whether a renal mass is benign or malignant.…”

Section: Imaging Characteristicsmentioning

confidence: 99%

See 3 more Smart Citations

Renal cell carcinoma, part 1

¹

2021

View full text Add to dashboard Cite

July l Nursing2021 l 35 THE AUTHOR'S journey with chronic illness began in 1998 at age 40, with a diagnosis of systemic lupus erythematosus (SLE). SLE and medications used to treat the disease increase the risk for infection. Several years ago, computed tomography (CT) of the chest, performed to confirm a diagnosis of right lower lobe pneumonia, revealed a 3-cm mass. A diagnosis of renal cell carcinoma (RCC) followed, along with a growing acquaintance with this disease. A partial nephrectomy was performed to remove the cancer, enabling a cancer-free life for the past 2 years.This article, the first of a three-part series on RCC, will address the incidence and epidemiology of RCC along with its genetic alterations, risk factors, histologic characteristics, and imaging characteristics. The subsequent articles will address treatment options and take a more detailed look at nursing interventions. Incidence and epidemiologyThe incidence of renal malignancy is 6 per 100,000 men and 3 per 100,000 women. Of all malignancies globally, it ranks 9th in men and 14th in women. 1 In the US, the incidence is 21 per 100,000 men and 11 per 100,000 women, representing the sixth and eighth most common malignancies in men and women, respectively. 1,2 According to the American Cancer Society, about 76,080 new cases of kidney cancer (48,780 in men and 27,300 in women) will be diagnosed in 2021, and about 13,780 people will die from this disease. 3 Sometimes referred to as renal cell adenocarcinoma or hypernephroma, RCC accounts for at least 85% of all renal malignancies and occurs more often than benign renal masses. 3 The incidence of RCC is highest in North America, Australia, and Europe, and lowest in India, Japan, Africa, and China. 1,2,4 Morbidity and mortality associated with RCC is higher for Black Americans, Native Americans, and Hispanics than for White patients, which is likely related to socioeconomic stressors, disparities in access to healthcare, and comorbidities. 1,4,5 Pathophysiology RCC encompasses a group of malignancies that originate in the Abstract: Renal cell carcinoma (RCC) encompasses a group of malignancies that originate in the epithelium of the renal cortex, most often in the upper pole of the kidney. This article, the first of a three-part series on RCC, addresses the incidence and epidemiology of RCC along with its genetic alterations, risk factors, histologic characteristics, and imaging characteristics.

Renal cell carcinoma, part 2

¹

2021

View full text Add to dashboard Cite

Renal cell carcinoma (RCC) accounts for most renal malignancies. This article, the second in a three-part series, addresses how renal masses are classified, signs and symptoms of RCC, medical treatments for RCC, and priority nursing interventions for patients with RCC.

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.